Arcutis Biotherapeutics, Inc. (ARQT)
25.42
-2.54
(-9.07%)
USD |
NASDAQ |
Feb 20, 16:00
24.80
-0.62
(-2.42%)
After-Hours: 20:00
Arcutis Biotherapeutics SG&A Expense (Quarterly) : 62.40M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| CorMedix, Inc. | 36.64M |
| ADMA Biologics, Inc. | 23.05M |
| ANI Pharmaceuticals, Inc. | 76.66M |
| Amicus Therapeutics, Inc. | 117.08M |
| Pacira Biosciences, Inc. | 81.65M |